FILE- Former French President Nicolas Sarkozy leaves after a Paris court sentenced him to 5 years after finding him guilty of ...

Scientists discover that a missing molecule, pleiotrophin, may disrupt brain circuits in Down syndrome; restoring it could ...

2025科创要闻No.43/ 10月13日-10月17日本期要闻汇总：林骏杰医药健康01 从头设计更安全有效的“AI胰岛素”10月13日，华盛顿大学、德克萨斯大学等机构的研究团队合作，在Cell子刊Molecular Cell ...

FDA has accepted Replimune’s RP1 resubmission for advanced melanoma treatment. ・Prescription Drug User Fee Act decision date ...

The U.S. Food and Drug Administration (FDA) has accepted Replimune's BLA resubmission for RP1 in combination with nivolumab, which targets advanced melanoma in patients who have not responded to prior ...

NEW YORK, NY, NY / ACCESS Newswire / October 20, 2025 / At Utah's White Mesa Mill, the smell of acid and ambition hangs in the air. Giant bags of monazite ore, each weighing more than a car, are ...

VANCOUVER, BC / ACCESS Newswire / October 20, 2025 / Empress Royalty Corp. ("Empress Royalty" or the "Company") is pleased to announce the appointment of Daniel Burns, JD, MBA, CPA, ...

BT-001 in combination with pembrolizumab is well tolerated and shows sustained antitumoral activity in both injected and ...

The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...

Head and neck cancer is the sixth most common cancer worldwide, with around 12,800 new cases each year in the UK alone ...

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...